Habib, A., Boateng, I., Abbott, D., Nicolet, D., Mrózek, K., Fisher, J., Waller, A., Buss, J., Laganson, A., Hamp, E., Abu-Shihab, Y., Powell, B., Uy, G., Stock, W., Stone, R., Kolitz, J., Wang, E., Carroll, A., Tyner, J., Hantel, A., Jordan, C., Paskett, E., Byrd, J., Mardis, E., Plascak, J., Eisfeld, A. (2025). Tri-partied analyses define clinical outcomes and molecular features of patients (pts) with acute promyelocytic leukemia (APL). Blood. https://doi.org/10.1182/blood-2025-8183